Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...

Clinical-stage biotherapeutics company PureTech Health has announced that the schizophrenia treatment it developed, which was ...

Shares of Neuland Laboratories rallied over 9% on Friday, September 27 after the United States Food and Drug Administration's ...

In company news, PureTech Health reported US Food & Drug Administration approval for its schizophrenia drug, and abrdn Property Income Trust agreed to sell a subsidiary for GBP351 million. Here is ...

These are the most popular stories from the Wall Street Journal. These stories have not been verified and we cannot vouch their accuracy. U.S.

In a filing to the stock exchange on September 26, the company said that it issued a total of 91,11,630 equity shares with a ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it entered into an agreement with Equity Pharmaceuticals PTY Limited, part of the Clinigen group, in September, to initiate a Named ...

Wolters Kluwer Tax and Accounting (TAA) today announced the expansion of its award-winning cloud-based practice management and compliance software platform, CCH iFirm, with the introduction of its ...